Nutrition Interventions for Cognitive Enhancement
NICE
Enhanced Mediterranean Diet for Alzheimer's Disease Prevention
2 other identifiers
interventional
209
1 country
1
Brief Summary
By doing this study, researchers hope to learn how the Mediterranean and low-fat eating patterns affect memory, brain volume, brain antioxidant status and cardio-metabolic biomarkers, such as blood pressure and blood glucose, in cognitively normal older adults. Researchers also plan to examine underlying processes relating the patterns to brain health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable alzheimer-disease
Started Mar 2019
Longer than P75 for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2019
CompletedFirst Posted
Study publicly available on registry
February 15, 2019
CompletedStudy Start
First participant enrolled
March 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2023
CompletedJune 7, 2024
June 1, 2024
4 years
January 18, 2019
June 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in a composite global cognition score
Alzheimer's Disease Cooperative Study-Preclinical Alzheimer Cognitive Composite (ADCS-PACC) and NIH Toolbox (NIH-TB) Cognition Battery and will be used to assess changes in a composite global cognition score at baseline, 6, and 12 months.
Baseline, 6 months and 12 months
Secondary Outcomes (29)
Change in Verbal Memory Factor
Baseline, 6 months and 12 months
Change in Visuospatial Processing Factor
Baseline, 6 months and 12 months
Change in Attention Factor
Baseline, 6 months and 12 months
Change in Executive Function Factor
Baseline, 6 months and 12 months
Change in Speed of Processing Factor
Baseline, 6 months and 12 months
- +24 more secondary outcomes
Study Arms (2)
Mediterranean Diet
EXPERIMENTALFollow a Mediterranean eating pattern and take a study supplement for one year. Dietary education will be provided by a Registered Dietitian.
Low-fat Diet
ACTIVE COMPARATORFollow a low-fat eating pattern and take a study supplement for one year. Dietary education will be provided by a Registered Dietitian.
Interventions
Diet consisting of fruits, vegetables, whole grains, low-fat dairy, olive oil, seafood, nuts and beans. It is low in red and processed meats, solid fats and added sugars.
Randomized to take a daily dose of either 2 grams of Omega 3 fatty acids or 2 grams of a Placebo.
Diet consisting of fruits, vegetables, whole grains, low-fat dairy, and low-fat protein, with fat contributing no more than 25% of calories.
Eligibility Criteria
You may qualify if:
- Cognitively normal older adults ≥65 years (MMSE score ≥ 25; AD8 score of 2 or less; no prior diagnosis of MCI, AD or dementia; and not medically treated for cognitive impairment or dementia)
- Speak English as a primary language
- Be able to read and write in English
- Live in the Kansas City, Metropolitan area
- Body Mass Index (BMI) range between 20 - 40 kg/m2
You may not qualify if:
- Serious medical risk, such as type 1 diabetes mellitus, cancer, recent cardiac event (e.g. heart attach, angioplasty)
- Taking the prescription drug Warfarin
- Taking a prescription fish oil, such as Lovaza, Omtryga, Vascepa, Epanova, etc., or prescribed a dose of over-the-counter (OTC) fish oil containing ≥300 mg Docohexanoic Acid (DHA) that cannot be adjusted to a lower dose
- Nut allergy, fish allergy (does not include shellfish)
- Adherence to specialized diet regimes (e.g., vegan, bariatric, renal, etc.) that make following either of the dietary plans impossible or unsafe
- Unwilling to be randomized to one of two diet interventions
- Evidence of severe major depression (GDS-SF ≥9) or presence of a major psychiatric disorder that in the investigator's opinion, could interfere with adherence to research assessments or procedures
- Alcohol (over 3 drinks per day or total of 18 per week) or drug abuse, defined as the use of chemical substances (prescription, OTC or illegal drugs) in a pattern that can lead to an increased risk of problems and an inability to control the use of the substance
- Do not have access to or independence over grocery shopping and meal preparation (i.e. those in military, retirement community with reliance on dining facilities for meals)
- Already consuming a Mediterranean diet as determined using the 14-item MedD Assessment Tool (score of ≥8)
- Already consuming a low-fat diet as determined by the NCI Percentage Energy from Fat Screener (≤ 15% of calories from fat)
- Already participating in another research study
- Another member of household is already participating in this study
- Have a visual impairment that greatly diminishes ability to read or write
- Currently attempting to lose weight
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Debra K Sullivan, PhD, RD
University of Kansas Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Raters - (psychometrician, brain magnetic resonance imaging (MRI), dual energy x-ray absorptiometry (DEXA), and phlebotomy) will be blinded to the intervention group and will perform outcome assessments.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair and Endowed Professor of Clinical Nutrition
Study Record Dates
First Submitted
January 18, 2019
First Posted
February 15, 2019
Study Start
March 7, 2019
Primary Completion
March 15, 2023
Study Completion
March 22, 2023
Last Updated
June 7, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share